Topiramate in Lennox-Gastaut Syndrome

J Gordon Millichap

doi:10.15844/pedneurbriefs-13-7-7

Topiramate in Lennox-Gastaut Syndrome

Pediatric Neurology Briefs

Volume 13 (1999): Issue 7

By: J Gordon Millichap

Open Access

|Jul 1999

Abstract

The efficacy and safety of topiramate as adjunctive therapy for Lennox-Gastaut syndrome were studied in an 11-week multicenter, double-blind, placebo-controlled trial involving 98 patients, 1-30 years of age, and reported from the New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ.

References

Sachdeo RC Glauser TA Ritter F Reife R Lim P Pledger G Topiramate YL Study Group A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome Neurology 1999 Jun 10 52 9 1882 1887 10.1212/WNL.52.9.1882 10371538
Open DOI Search in Google Scholar Back to article
Rosenfeld WE Doose DR Walker SA Baldassarre JS Reife RA A study of topiramate pharmacokinetics and tolerability in children with epilepsy Pediatr Neurol 1999 May 20 5 339 344 10.1016/S0887-8994(99)00011-9 10371378
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-13-7-7 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 53 - 53

Published on: Jul 1, 1999

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Topiramate,

Lennox-Gastaut Syndrome,

Anorexia

© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 13 (1999): Issue 7